These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5633533)

  • 1. [Low molecular weight dextran and fibrinolysis in men. II. Fibrinolysis activation by administering low molecular weight dextran in lymphedema].
    Tesi M; Brunetti S
    Riv Crit Clin Med; 1967 Aug; 67(3):216-32. PubMed ID: 5633533
    [No Abstract]   [Full Text] [Related]  

  • 2. [Low molecular weight dextran and fibrinolysis in humans. I. Comparison between fibrinolysis activation by administering low molecular weight dextran by intravenous and intra-arterial routes].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Aug; 67(3):200-15. PubMed ID: 5633532
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intra-arterial therapy of peripheral arterial occlusive disease with oxyfedrine and low-molecular dextran].
    Cachovan M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1940-3. PubMed ID: 1030142
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activation of the fibrinolytic system by low-molecular dextran].
    Fischer M; Wimmer H
    Bibl Haematol; 1965; 23():1278-83. PubMed ID: 5885216
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombotic effect of hemodilution with dextran. Studies on the mechanism of action.
    Aberg M; Bergentz SE; Hedner U
    Bibl Haematol; 1975; (41):125-32. PubMed ID: 1180824
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with low molecular weight dextran in patients with thrombocytosis.
    Tytgat GN; De Vreker RA; Lust A
    Acta Anaesthesiol Belg; 1968; 19(2):183-92. PubMed ID: 5746328
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of various drugs on the dynamics of fibrinolysis in humans].
    Brunetti S; Tesi M
    Riv Crit Clin Med; 1967 Aug; 67(3):233-45. PubMed ID: 5633715
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of infusion of dextran 70 on fibrinolysis inhibition activity in human serum.
    Carlin G; Modig J; Saldeen T
    Acta Chir Scand; 1979; 145(3):129-31. PubMed ID: 494957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of single intravenous infusion of low-molecular weight dextran on acid-base equilibrium and erythrocytes and some spirometric indices in chronic cor pulmonale syndrome].
    Gondorowicz K; Religa H; Rozniecki J
    Pol Tyg Lek; 1973 Mar; 28(13):469-72. PubMed ID: 4698724
    [No Abstract]   [Full Text] [Related]  

  • 10. [The progress and the fibrinolytic activity of the diabetic retinopathy treated with dextran sulfate (author's transl)].
    Mine T
    Nippon Ganka Gakkai Zasshi; 1975 Apr; 79(4):371-5. PubMed ID: 1170740
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran.
    Cunliffe WJ; Menon IS
    Br J Dermatol; 1969 Mar; 81(3):220-5. PubMed ID: 5775073
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of intra-arterial fibrinolysis in subacute atheromatous ischemia of the lower limbs].
    Enon B; Chevalier JM; Talha H; Lescalie F; L'Hoste P; Pillet J
    J Chir (Paris); 1991 Apr; 128(4):182-7. PubMed ID: 2055982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of iterative perfusions with low molecular weight dextran in long-term treatment of retinal venous occlusions].
    Cordier J; Raspiller A; Bowyer M; Vouters H
    Bull Soc Ophtalmol Fr; 1978 Nov; 78(11):795-9. PubMed ID: 755549
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conventional local intra-arterial fibrinolysis, spray lysis and mechanically accelerated fibrinolysis. An assessment of their position in the spectrum of angioplasty technics].
    Wagner HJ; Starck E; Alfke H; Reuter P
    Rofo; 1993 Nov; 159(5):466-70. PubMed ID: 8219142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in arterial blood fibrinolytic activity in patients with unstable angina on various molecular-weight heparins].
    Kolodchenko IeV
    Lik Sprava; 2001; (3):122-30. PubMed ID: 11559998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of atherosclerotic peripheral arterial insufficiency with low molecular weight dextran intravenously.
    Lewis SR; Johnson JB
    J Natl Med Assoc; 1966 Jul; 58(4):261-4. PubMed ID: 5947681
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the utilization, during peripheral angiographies, of a solution of polysaccharides of low molecular weight (40,000) derived from Dextran].
    Chassaigne JP; Voglimacci JP; Marque B; Tingaud R
    J Med Bord; 1967 Jan; 144(1):165-7. PubMed ID: 5597404
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blocking effect of atropine on fibrinolysis induced by acetylcholine and bradykinin].
    Tesi M; Brunetti S
    Riv Crit Clin Med; 1967 Aug; 67(3):256-70. PubMed ID: 5633534
    [No Abstract]   [Full Text] [Related]  

  • 20. Low molecular weight dextran.
    Honeybourne D
    Br Med J; 1977 Jan; 1(6052):52-3. PubMed ID: 831998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.